Cyclooxygenase 2 inhibitors: discovery, selectivity and the future
- 1 November 1999
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 20 (11), 465-469
- https://doi.org/10.1016/s0165-6147(99)01385-1
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Cyclooxygenase in biology and diseaseThe FASEB Journal, 1998
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Mechanism of Action of Anti-Inflammatory DrugsScandinavian Journal of Rheumatology, 1996
- Prostaglandin synthase 2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomasGastroenterology, 1994
- Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.Journal of Clinical Investigation, 1994
- Differentiation of Monocytoid THP-1 Cells with Phorbol Ester Induces Expression of Prostaglandin Endoperoxide Synthase-1 (COX-1)Biochemical and Biophysical Research Communications, 1993
- Human cyclooxygenase-2 cDNA.Proceedings of the National Academy of Sciences, 1992
- Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugsDrug Development Research, 1992
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971